Amitriptyline

Amitriptyline

SCHEMBL3897883

CN(C)CCC=C1c2ccccc2CCc2ccccc21.CNCCC=C1c2ccccc2CCc2ccccc21

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A4

The experimentally established mechanism targets of Amitriptyline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 8/20 0.81
SLC6A4 known ✓ P31645 6/20 0.81
HRH1 P35367 8/20 0.81
LMNA P02545 7/20 0.81
HTR2B P41595 7/20 0.81
KCNH2 Q12809 7/20 0.81
CYP2D6 P10635 6/20 0.81
CHRM2 P08172 6/20 0.81
CHRM1 P11229 6/20 0.81
DRD2 P14416 6/20 0.81
ADRA2C P18825 6/20 0.81
CHRM3 P20309 6/20 0.81
HTR2A P28223 6/20 0.81
HTR2C P28335 6/20 0.81
ADRA1A P35348 6/20 0.81
DRD3 P35462 6/20 0.81
OPRK1 P41145 5/20 0.81
ADRA2A P08913 5/20 0.81
ADRA2B P18089 5/20 0.81
CYP1A2 P05177 5/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nortriptyline SCHEMBL34527 0.90 SLC6A2 (1.00) SLC6A2HRH1LMNAHTR2BKCNH2
Nortriptyline SCHEMBL1286980 0.90 SLC6A2 (1.00) SLC6A2HRH1LMNAHTR2BKCNH2
Amitriptyline SCHEMBL29359365 0.90 SLC6A2 (1.00) SLC6A2HRH1LMNAHTR2BKCNH2
Amitriptyline SCHEMBL2877708 0.90 SLC6A2 (1.00) SLC6A2HRH1LMNAHTR2BKCNH2
Amitriptyline SCHEMBL7824 0.90 SLC6A2 (1.00) SLC6A2HRH1LMNAHTR2BKCNH2
Nortriptyline SCHEMBL29362430 0.90 SLC6A2 (1.00) SLC6A2HRH1LMNAHTR2BKCNH2
Dothiepin SCHEMBL4076290 0.89 SLC6A2 (0.78) SLC6A2HRH1LMNAHTR2BKCNH2
Amitriptyline SCHEMBL14937172 0.88 SLC6A2 (1.00) SLC6A2HRH1LMNAHTR2BKCNH2
Nortriptyline SCHEMBL7158809 0.88 SLC6A2 (0.97) SLC6A2HRH1LMNAHTR2BKCNH2
Amitriptyline SCHEMBL7215255 0.88 SLC6A2 (0.97) SLC6A2HRH1LMNAHTR2BKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240181077-A1 AN ARTIFICIAL PROTEIN-CAGE COMPRISING ENCAPSULATED THEREIN A GUEST CARGO UNIWERSYTET JAGIELLONSKI (PL) 2024-06-06 US disclosed
US-20240139339-A1 AN ARTIFICIAL PROTEIN-CAGE DECORATED WITH PARTICULAR MOLECULES ON THE EXTERIOR UNIWERSYTET JAGIELLONSKI (PL) 2024-05-02 US disclosed
EP-4298115-A1 AN ARTIFICIAL PROTEIN-CAGE DECORATED WITH PARTICULAR MOLECULES ON THE EXTERIOR UNIWERSYTET JAGIELLONSKI (PL) 2024-01-03 EP disclosed
EP-4298117-A1 AN ARTIFICIAL PROTEIN-CAGE COMPRISING ENCAPSULATED THEREIN A GUEST CARGO UNIWERSYTET JAGIELLONSKI (PL) 2024-01-03 EP disclosed
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
EP-1703907-A4 COMPOSITIONS AND METHODS TO TREAT RECURRENT MEDICAL CONDITIONS MCDEVITT JASON (US) 2009-03-25 EP disclosed
EP-1703907-A2 COMPOSITIONS AND METHODS TO TREAT RECURRENT MEDICAL CONDITIONS McDevitt, Jason (US) 2006-09-27 EP disclosed
WO-2005065308-A2 COMPOSITIONS AND METHODS TO TREAT RECURRENT MEDICAL CONDITIONS MCDEVITT JASON (US) 2005-07-21 WO disclosed
US-4310524-A TCA Composition and method for rapid onset antidepressant therapy RICHARDSON-MERRELL, INC. (US) 1982-01-12 US disclosed